Mirae Asset Global Investments Co., Ltd. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$5,645,756
-4.4%
58,5050.0%0.01%
-7.7%
Q2 2023$5,903,740
+127.5%
58,505
+107.4%
0.01%
+116.7%
Q1 2023$2,594,768
-44.2%
28,204
-45.0%
0.01%
-50.0%
Q4 2022$4,654,027
-1.0%
51,301
-17.0%
0.01%
-7.7%
Q3 2022$4,700,000
-57.6%
61,832
-52.8%
0.01%
-53.6%
Q2 2022$11,074,000
-53.1%
131,003
-51.4%
0.03%
+12.0%
Q1 2022$23,634,000
+89.8%
269,318
+89.2%
0.02%
-7.4%
Q4 2021$12,451,000
+4.0%
142,345
-2.8%
0.03%
-10.0%
Q3 2021$11,973,000
-10.5%
146,405
-0.2%
0.03%
-18.9%
Q2 2021$13,378,000
+6.6%
146,627
-0.1%
0.04%
-15.9%
Q1 2021$12,552,000
-9.6%
146,832
-0.1%
0.04%
-15.4%
Q4 2020$13,883,000
+48.8%
147,015
+37.1%
0.05%
+13.0%
Q3 2020$9,327,000
-18.9%
107,255
-18.5%
0.05%
-33.3%
Q2 2020$11,495,000
+0.3%
131,617
-5.3%
0.07%
-23.3%
Q1 2020$11,464,000
-14.1%
139,038
-1.4%
0.09%
+8.4%
Q4 2019$13,350,000
+25.7%
140,988
+15.4%
0.08%
+12.2%
Q3 2019$10,620,000
-8.2%
122,205
-3.5%
0.07%
-6.3%
Q2 2019$11,565,000
+48.8%
126,658
+37.9%
0.08%
+38.6%
Q1 2019$7,770,000
-31.3%
91,864
-30.2%
0.06%
-44.1%
Q4 2018$11,302,000
+21.6%
131,697
+22.0%
0.10%
+47.8%
Q3 2018$9,297,000
+58.4%
107,908
+38.9%
0.07%
-13.8%
Q2 2018$5,868,000
-6.7%
77,681
-0.1%
0.08%
-2.4%
Q1 2018$6,288,000
-0.5%
77,774
+3.3%
0.08%
-3.5%
Q4 2017$6,321,000
+14.4%
75,297
+17.0%
0.08%
-15.8%
Q3 2017$5,523,000
+20.1%
64,329
+16.8%
0.10%
+26.2%
Q2 2017$4,599,000
-5.7%
55,095
-16.1%
0.08%
-12.1%
Q1 2017$4,877,000
+41.6%
65,667
+38.8%
0.09%
+18.2%
Q4 2016$3,445,000
-19.2%
47,297
-12.4%
0.08%
-12.5%
Q3 2016$4,262,000
+222.4%
53,970
+236.9%
0.09%
+158.8%
Q2 2016$1,322,000
-16.0%
16,021
-26.2%
0.03%
-20.9%
Q1 2016$1,573,000
-65.5%
21,720
-59.1%
0.04%
-71.5%
Q4 2015$4,565,000
+2.1%
53,057
+9.1%
0.15%
-17.5%
Q3 2015$4,472,000
-10.5%
48,650
-4.2%
0.18%
+14.4%
Q2 2015$4,996,000
+0.7%
50,800
+1.0%
0.16%
-5.3%
Q1 2015$4,960,000
+12.7%
50,300
+5.9%
0.17%
+5.6%
Q4 2014$4,400,000
+19.9%
47,490
+21.8%
0.16%
+21.2%
Q3 2014$3,671,000
+20.3%
39,000
+15.7%
0.13%
+94.1%
Q2 2014$3,051,000
+11.8%
33,700
+5.0%
0.07%
-1.4%
Q1 2014$2,729,000
+151.5%
32,100
+137.8%
0.07%
+50.0%
Q4 2013$1,085,000
+4.7%
13,5000.0%0.05%
-2.1%
Q3 2013$1,036,000
+8.5%
13,5000.0%0.05%
-7.8%
Q2 2013$955,00013,5000.05%
Other shareholders
NOVARTIS A G shareholders Q4 2021
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 237,047$19,165,0006.16%
PRENTISS SMITH & CO INC 127,005$10,268,0005.38%
EXENCIAL WEALTH ADVISORS, LLC 195,903$15,839,0004.71%
Osher Van de Voorde Investment Management 106,315$8,596,0004.37%
BROWN BROTHERS HARRIMAN & CO 8,924,544$721,549,0004.16%
CGOV Asset Management 874,998$70,744,0004.08%
PROFESSIONAL ADVISORY SERVICES INC 218,844$17,694,0003.83%
COMPASS CAPITAL MANAGEMENT, INC 304,931$24,654,0003.69%
First Fiduciary Investment Counsel, Inc. 226,636$18,324,0003.64%
SUMMITRY LLC 456,575$36,914,0003.41%
View complete list of NOVARTIS A G shareholders